GABRB3, gamma-aminobutyric acid type A receptor subunit beta3, 2562
N. diseases: 139; N. variants: 56
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.020 | < 0.001 | 2 | 2007 | 2012 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.020 | < 0.001 | 2 | 2007 | 2012 | |||||||
|
15 | 26758948 | intron variant | T/A | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
15 | 26732026 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||||
|
1.000 | 0.040 | 15 | 26577667 | intron variant | G/A | snv | 0.43 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
15 | 26793345 | intron variant | C/A | snv | 0.42 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
15 | 26748096 | intron variant | C/T | snv | 0.91 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.040 | 15 | 26575978 | intron variant | A/G | snv | 0.46 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
15 | 26565542 | intron variant | A/G;T | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 15 | 26773790 | intron variant | G/A;C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 15 | 26553052 | intron variant | T/C | snv | 0.12 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
15 | 26768806 | intron variant | T/A | snv | 0.91 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.080 | 15 | 26766994 | intron variant | C/T | snv | 0.32 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 15 | 26766994 | intron variant | C/T | snv | 0.32 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 15 | 26766994 | intron variant | C/T | snv | 0.32 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 15 | 26766994 | intron variant | C/T | snv | 0.32 |
|
0.800 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
15 | 26764379 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||||
|
15 | 26777184 | intron variant | G/C | snv | 0.89 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
15 | 26733600 | intron variant | A/C;T | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 |